Skip to content
Screener

Incyte INCY Other Non-Current Assets

Other Non-Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$6.38B+7.4%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$15.43M+66.0%
Gilead Sciences logo
Gilead SciencesGILD
$295M-20.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$832K
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$465K+1,400%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$2.2M-26.5%

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$24.28B+60.1%
Enterprise value$20.34B+53.5%
P/E15.1×-2.4×
P/S4.2×+0.9×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Return on equity30.7%+6.4pp
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Incyte’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000879169-26-000056
Line itemJune 30,2026December 31,2025*
Other intangible assets, net103,196117,131
Goodwill133,000133,000
Deferred income tax asset336,863515,294
Other assets, net86,75918,166
Total assets$7,872,647$6,957,973
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$250,401$209,938

Item 1. Financial Statements

FAQ

What is Incyte's other non-current assets?
Incyte (INCY) reported other non-current assets of $86.76M in Q2 2026.
How has Incyte's other non-current assets changed year-over-year?
Incyte's other non-current assets increased by 166.5% year-over-year, from $32.55M to $86.76M.
What is the long-term trend for Incyte's other non-current assets?
Over 5 years (2020 to 2025), Incyte's other non-current assets has grown at a -15.2% compound annual growth rate (CAGR), from $41.46M to $18.17M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Incyte's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude